Abstract
Different mouse models have been generated to understand the molecular mechanisms involved in human tumorigenesis. Some of these models are produced by gene-targeting procedures, whereas others use the normal mouse as an experimental animal. The pathogenetic relevance of these mouse models has generated optimism for the development of effective targeted therapies, advances in rational drug design and has provided valuable information about human cancer disease. By combining genetic analysis and molecule screening techniques, the mouse is emerging as a powerful system for identifying novel cancer genes and for cancer drug discovery. However, there are both parallelisms and discrepancies between mouse and human carcinogenesis important for elucidating the human disease process.
Keywords: mouse models, human genetic diseases, drug discovery
Letters in Drug Design & Discovery
Title: Cancer Genetics and Drug Discovery in Mice
Volume: 1 Issue: 4
Author(s): Manuel Sanchez-Martín, Ines Gonzalez-Herrero and Isidro Sanchez-Garcia
Affiliation:
Keywords: mouse models, human genetic diseases, drug discovery
Abstract: Different mouse models have been generated to understand the molecular mechanisms involved in human tumorigenesis. Some of these models are produced by gene-targeting procedures, whereas others use the normal mouse as an experimental animal. The pathogenetic relevance of these mouse models has generated optimism for the development of effective targeted therapies, advances in rational drug design and has provided valuable information about human cancer disease. By combining genetic analysis and molecule screening techniques, the mouse is emerging as a powerful system for identifying novel cancer genes and for cancer drug discovery. However, there are both parallelisms and discrepancies between mouse and human carcinogenesis important for elucidating the human disease process.
Export Options
About this article
Cite this article as:
Sanchez-Martín Manuel, Gonzalez-Herrero Ines and Sanchez-Garcia Isidro, Cancer Genetics and Drug Discovery in Mice, Letters in Drug Design & Discovery 2004; 1 (4) . https://dx.doi.org/10.2174/1570180043398704
DOI https://dx.doi.org/10.2174/1570180043398704 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials Non-Photoinduced Biological Properties of Verteporfin
Current Medicinal Chemistry Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Current Stem Cell Research & Therapy Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy
Current Medicinal Chemistry Biomarkers Downstream of RAS: A Search for Robust Transcriptional Targets
Current Cancer Drug Targets Fas Ligand Gene Therapy for Vascular Intimal Hyperplasia
Current Gene Therapy Recent Advances in Computer-Assisted Structure-Based Identification and Design of Histone Deacetylases Inhibitors
Current Topics in Medicinal Chemistry The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics Regulatory Circuitries Coordinated by Transcription Factors and microRNAs at the Cornerstone of Hematopoietic Stem Cell Self-Renewal and Differentiation
Current Stem Cell Research & Therapy Discovery of BRM Targeted Therapies: Novel Reactivation of an Anticancer Gene
Letters in Drug Design & Discovery Proteomic Classification of Breast Cancer
Current Drug Targets Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Current Drug Targets Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy NF-κB as a Therapeutic Target for Transcription Factor Decoy Strategy in Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis
Current Cancer Drug Targets Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Quality of Life of Children with Cerebral Palsy: A Cross-Sectional KIDSCREEN study in the Southern part of the Netherlands
CNS & Neurological Disorders - Drug Targets